Stock Taper
SCREENER COMPARE ANY 2 STOCKS
APLMW
APOLLOMICS, INC.
NASDAQ
$0.01
▼ DOWN 2.10% (-0.00)

KEY STATISTICS

Market Cap$206.92 M
52w High$0.03
52w Low$0.01
Dividend Yield—
Frequency—
P/E—
Volume9.29K
Shares Out.14.78B

COMPANY

LEADERSHIP

Hung-Wen Chen
CHIEF EXECUTIVE
Hung-Wen Chen

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 30, 2023
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
14

UPCOMING EARNINGS

DateSep 24, 2026
DayThursday
Rev. Est.—
SEP
24
THU

PRICE

$0.01 ▼ DOWN 2.10% (−$0.00)
$0.01$0.01$0.01$0.01$0.0112:09 PM12:46 PM1:23 PM2:00 PM2:36 PM3:13 PM3:50 PM0.01

About Apollomics, Inc.

https://www.apollomicsinc.com ↗

Apollomics, Inc. is a clinical-stage biotech company founded in 2015 in Foster City, CA, focused on discovering and developing oncology therapies to meet unmet medical needs.

INDUSTRY

Biotechnology

A PRODUCT APOLLOMICS, INC. IS KNOWN FOR

Vebreltinib (APL-101)
Vebreltinib (APL-101)

Vebreltinib is an orally administered, highly selective c-Met inhibitor currently in Phase 2 clinical trials. It is Apollomics' lead product candidate for treating non-small cell lung cancer and other advanced tumors with c-Met alterations.

COMPETITORS

COMPETITOR
ABBV COMPARE
IDYA COMPARE
NVS COMPARE
PYXS COMPARE
REGN COMPARE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
0.03%
HOLDERS
18
TOP 12 OF 18 · RANKED BY POSITION SIZE
Clear Street Group Inc.
1.0M sh · $19.17K
Clear Street LLC
506.8K sh · $22.45K
Clear Street Derivatives LLC
497.4K sh · $22.03K
Atw Spac Management LLC
373.7K sh · $7.14K
Boothbay Fund Management, LLC
373.7K sh · $6.99M
D. E. Shaw & Co., Inc.
318.5K sh · $6.37K
Context Capital Management, LLC
298.5K sh · $4.54K
Susquehanna International Group, Llp
281.6K sh · $5.38K
Mmcap International Inc. Spc
250.0K sh · $3.8K
Wolverine Asset Management LLC
167.4K sh · $2.54K
683 Capital Management, LLC
130.0K sh · $1.44K
Citadel Advisors LLC
105.6K sh · $2.01K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR
Huang Ya-Chi
Purchase · 500 shares
2026-08-17
★
DIRECTOR
Huang Ya-Chi
Sale · 500 shares
2026-08-17
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Chen Hung-Wen
Purchase · 266.7K shares
2026-08-14
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Chen Hung-Wen
Purchase · 166.7K shares
2026-08-14

SECTORS PEERS

PEERPRICE
TDAC$10.84COMPARE
PLMK$10.73COMPARE